Raclopride inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets D1 receptor, D2 receptor, D3 receptor, and D4 receptor.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.